The New York Times

A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in later stages of the disease.

Dr. Jay Bhattacharya will serve as acting director of the Centers for Disease Control and Prevention until President Trump appoints a permanent director.

In the oceans and on land, scientists are discovering rare, transitional organisms that bridge the gap between Earth’s simplest cells and today’s complex ones.

Moderna said it had held further discussions with regulators and announced that the agency would accept the company’s application for approval of its flu vaccine that uses mRNA technology.

In the Lost Science series, scientists whose jobs or funding have been cut by the Trump administration tell their stories.

Kathleen Chalfant, Elizabeth Marvel, April Matthis and other actors deliver top-notch performances in a play that leaves questions unanswered.

The Tony winner returns to the stage in “Every Brilliant Thing,” an interactive monologue with a message of hope “that might be vital for somebody to hear.”

Federal policies under Robert F. Kennedy Jr. that are hostile to vaccines have “sent a chill through the entire industry,” one scientist said.

More than 40 people have fallen ill at Ave Maria University, raising fears that college campuses may soon experience more measles outbreaks.

Proponents of vaccines warn that the efforts will further dismantle the immunization infrastructure and lead to more outbreaks of disease.

Health workers in developing countries know that isolating tuberculosis patients is an outdated and potentially harmful practice, but lack the resources to move away from it.